Breast cancer TICs with the canonical CD44+/CD24-/EpCAM+ signature showed massive upregulation of FA biosynthesis enzymes FASN, ACLY, ACC1 and the master regulator SREBP1 [43]. Here, CD44 is linked to breast carcinoma.